Immune Checkpoint Molecules—Inherited Variations as Markers for Cancer Risk
In recent years, immunotherapy has been revolutionized by a new approach that works by blocking receptors called immune checkpoints (IC). These molecules play a key role in maintaining immune homeostasis, mainly by suppressing the immune response and by preventing its overactivation. Since inhibitio...
Main Authors: | Marta Wagner, Monika Jasek, Lidia Karabon |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-01-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2020.606721/full |
Similar Items
-
Evaluation of the immune checkpoint factors in idiopathic membranous nephropathy
by: Roza Motavalli, et al.
Published: (2023-06-01) -
Effects of intermittent T-cell cluster disaggregation on proliferative capacity and checkpoint marker expression
by: Matthew Li, et al.
Published: (2019-04-01) -
Targeting Immune Cell Checkpoints during Sepsis
by: Naeem K. Patil, et al.
Published: (2017-11-01) -
Immune Checkpoint Molecules on Tumor-Infiltrating Lymphocytes and Their Association with Tertiary Lymphoid Structures in Human Breast Cancer
by: Cinzia Solinas, et al.
Published: (2017-10-01) -
Not All Immune Checkpoints Are Created Equal
by: Annika De Sousa Linhares, et al.
Published: (2018-08-01)